Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Zahn

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
Circulation|December 21, 2018
Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve StenosisNicolas Werner, Ralf Zahn, Andreas Beckmann, et al.
The American Journal of Cardiology|December 9, 2022
Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical PracticeUwe Zeymer, Ralph Toelg, Harm Wienbergen, et al.
Herz|March 4, 2022
Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in GermanyUwe Zeymer, Ralph Toelg, Harm Wienbergen, et al.
International Journal of Cardiology|August 30, 2018
Long-term outcome, survival and predictors of mortality after MitraClip therapy: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registryDaniel Kalbacher, Ulrich Schäfer, R Stephan V Bardeleben, et al.
American Heart Journal|July 17, 2012
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions RegistryJan-Malte Sinning, Martin Horack, Eberhard Grube, et al.
Stroke|October 30, 2010
Ongoing randomized controlled trials comparing interventional methods and optimal medical treatment in the treatment of asymptomatic carotid stenosisTilman Reiff, Dittmar Böckler, Michael Böhm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 22, 2014
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)Alexander Lauten, Hans R Figulla, Helge Möllmann, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 26, 2021
Contralateral Stenosis and Echolucent Plaque Morphology are Associated with Elevated Stroke Risk in Patients Treated with Asymptomatic Carotid Artery Stenosis within a Controlled Clinical Trial (SPACE-2)Tilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, et al.
The Lancet. Neurology|September 17, 2022
Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trialTilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, et al.
Cardiology and Therapy|December 6, 2023
Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI TrialMartin Borlich, Uwe Zeymer, Harm Wienbergen, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Circulation|December 21, 2018
Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve StenosisNicolas Werner, Ralf Zahn, Andreas Beckmann, et al.
The American Journal of Cardiology|December 9, 2022
Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical PracticeUwe Zeymer, Ralph Toelg, Harm Wienbergen, et al.
Herz|March 4, 2022
Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in GermanyUwe Zeymer, Ralph Toelg, Harm Wienbergen, et al.
International Journal of Cardiology|August 30, 2018
Long-term outcome, survival and predictors of mortality after MitraClip therapy: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registryDaniel Kalbacher, Ulrich Schäfer, R Stephan V Bardeleben, et al.
American Heart Journal|July 17, 2012
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions RegistryJan-Malte Sinning, Martin Horack, Eberhard Grube, et al.
Stroke|October 30, 2010
Ongoing randomized controlled trials comparing interventional methods and optimal medical treatment in the treatment of asymptomatic carotid stenosisTilman Reiff, Dittmar Böckler, Michael Böhm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 22, 2014
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)Alexander Lauten, Hans R Figulla, Helge Möllmann, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 26, 2021
Contralateral Stenosis and Echolucent Plaque Morphology are Associated with Elevated Stroke Risk in Patients Treated with Asymptomatic Carotid Artery Stenosis within a Controlled Clinical Trial (SPACE-2)Tilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, et al.
The Lancet. Neurology|September 17, 2022
Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trialTilman Reiff, Hans-Henning Eckstein, Ulrich Mansmann, et al.
Cardiology and Therapy|December 6, 2023
Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI TrialMartin Borlich, Uwe Zeymer, Harm Wienbergen, et al.
Pageof 21